Sign in

CIK 0000059478

  • Large accelerated filer

ELI LILLY & Co

Sign in to watch
Ticker
LLY
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
IN
Entity type
Operating
EIN
350470950
Phone
+1 317-276-2000
Business address
LILLY CORPORATE CTR, DROP CODE 1094, INDIANAPOLIS, IN, 46285
Former names
LILLY ELI & CO, LILLY ELI & CO ET AL
  1. 4 Grant or award Director acquired 7.1 shares (grant or award)
  2. 4 Grant or award Director acquired 21.25 shares (grant or award)
  3. 4 Grant or award Director acquired 14.21 shares (grant or award)
  4. 4 Grant or award Director acquired 14.21 shares (grant or award)
  5. 4 Grant or award Director acquired 16.83 shares (grant or award)
  6. 4 Open-market buy EVP & CFO bought 715 shares at $691.79 ($494,627)
  7. 4 Open-market buy Director bought 758 shares at $660.25 ($500,473)
  8. 4 Open-market buy EVP & Pres., Lilly Oncology bought 1,000 shares at $647.36 ($647,360)
  9. 4 Open-market buy President, Chair, and CEO bought 1,632 shares at $644.77 ($1,052,263)
  10. 4 Open-market buy EVP, CSO & Pres. LRL & LLY Imm bought 1,000 shares at $634.41 ($634,405)
  11. 4 Open-market buy Director bought 117 shares at $641.18 ($75,018)
  12. 4 Open-market buy Director bought 1,565 shares at an average $642.33 ($1,005,242)
  13. 4 Planned sale EVP&Pres, LLY USA&Global Capab sold 1,250 shares at $627.01 ($783,763)
  14. 4 Open-market buy Director bought 200 shares at $639.56 ($127,913)
  15. 4 Shares withheld for taxes EVP, Global Quality gave up 426.92 shares (to pay taxes)
  16. 4 Open-market sale 10% owner sold 280,000 shares at an average $805.07 ($225,419,259)
  17. 4 Grant or award Director acquired 19.46 shares (grant or award)
  18. 4 Grant or award Director acquired 6.51 shares (grant or award)
  19. 4 Grant or award Director acquired 13.01 shares (grant or award)
  20. 4 Grant or award Director acquired 13.01 shares (grant or award)

Page 9 of 142 · 2,824 filings